TB500 is a synthetic version of an active region of thymosin beta4. TB500 exhibits anti-fibrotic and wound healing activities by inhibiting the Akt signaling pathway and binding to actin. TB500 is claimed to promote endothelial cell differentiation, angiogenesis in dermal tissues, keratinocyte migration, collagen deposition and decrease inflammation[1][2][3].
Molecular Weight:
889.01
Purity:
99.81
CAS Number:
[885340-08-9]
Formula:
C38H68N10O14
Target:
Akt,Drug Derivative,P2X Receptor
Application Notes:
Peptides
* VAT and and shipping costs not included. Errors and price changes excepted
